TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00953706 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT02823548 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01693419 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01693419 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01466881 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT00391755 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study NCT04128839 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00753012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04084301 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00726661 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00726661 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00726661 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00726661 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03794180 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02207166 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03573258 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03573258 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01320280 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00365638 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03588845 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study NCT00665067 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT01312337 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01513135 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02500654 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT00001384 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03709719 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study NCT00549536 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04097210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04097210 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT01204788 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02034240 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02457026 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01424800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04304560 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04304560 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03239457 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01141530 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01141530 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00498225 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00498225 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT03319641 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03319641 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT00243854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04554303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00373269 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT03354039 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04014933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02861937 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT00844506 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01451411 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04224519 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00020254 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00020254 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01785004 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00637234 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00637234 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00637234 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05398965 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02493764 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT01482130 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05321329 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01612676 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02841553 — Predictive Biomarker (PRD): WFS1 mRNA
Genes: WFS1
Study NCT00545077 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00545077 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03364153 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03407768 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03684213 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00185094 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02638909 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02638909 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02022540 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00036036 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02259114 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02259114 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02709174 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04652076 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT04135378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03103971 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01595321 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01423552 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02430740 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00739791 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01205503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01889693 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05701787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05701787 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01485848 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02008084 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02008084 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02008084 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01059747 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01059747 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01059747 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01059747 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00299741 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00299741 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03448042 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03448042 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03096886 — Predictive Biomarker (PRD): GDA mRNA
Genes: GDA; KIAA1258
Study NCT04397796 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04891887 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01468545 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02199041 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT04462601 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03836443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01607372 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT00583167 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01351272 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT03542630 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT03888248 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02487316 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00535977 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01845467 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT01811108 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01517542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01557998 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02740686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02828423 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT01590953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00913913 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00913913 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00913913 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01137799 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT01137799 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT03710564 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03710564 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00572078 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03571191 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT03571191 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02508896 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02508896 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06360575 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04344613 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT00647543 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00530881 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03702179 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04401774 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04564989 — Predictive Biomarker (PRD): TRAF3 mRNA
Genes: TRAF3; CAP-1; CRAF1; TRAFAMN
Study NCT04564989 — Predictive Biomarker (PRD): CYLD mRNA
Genes: CYLD; CYLD1; KIAA0849; HSPC057
Study NCT04162119 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04162119 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04162119 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT02142348 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04307316 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00525421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00525421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02307565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02393859 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05065658 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00602693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00602693 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03257358 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03257358 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study NCT03257358 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03257358 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02982265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03094767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02710149 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00022438 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04279743 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04353830 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT02786602 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT02786602 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study NCT02786602 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02918526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04340154 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04340154 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02805790 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT01478984 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01164007 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04225858 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03491696 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT02953080 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03747354 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT04048018 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01097343 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03253913 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT03253913 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03630939 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03900637 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03900637 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT01205620 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01205620 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00089739 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT00266513 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study NCT00266513 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00114699 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04303780 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03490851 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02491723 — Predictive Biomarker (PRD): NLRC4 mRNA
Genes: NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215
Study NCT02507154 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00141778 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00940316 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00940316 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01893710 — Predictive Biomarker (PRD): AQP1 mRNA
Genes: AQP1; CHIP28
Study NCT01306292 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01120405 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT01465841 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03026244 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT00234091 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03199235 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT00244621 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01220492 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01220492 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03882281 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00820547 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04236271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01173679 — Predictive Biomarker (PRD): LYN mRNA
Genes: LYN; JTK8
Study NCT02072213 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04714502 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT02570191 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04401358 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT00414999 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04870060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04870060 — Safety Biomarker (SAF): Interleukin 1
Study NCT04870060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04870060 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04870060 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT04846335 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study NCT02695290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02695290 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04633980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04633980 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00328393 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04264039 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04168931 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03885583 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01523002 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04172246 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04086680 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04086680 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05295134 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03648710 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02918032 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00001937 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02338245 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02550015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03425058 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03425058 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03347942 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03381287 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02173444 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06715176 — Predictive Biomarker (PRD): PGLYRP
Genes: PGLYRP1; TAG7; PGRP; PGRP-S; PGRPS
Study NCT01700231 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04327323 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02798718 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04574635 — Monitoring Biomarker (MOI): Circulating tumor HPV DNA
Study NCT04574635 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02842424 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02951637 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00054743 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03893526 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03430349 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02636855 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02122380 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01444820 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01444820 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04603001 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04603001 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04083417 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT02871999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02871999 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00244855 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01607619 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01362920 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01831791 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT01581684 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19